Prevention and screening recommendations in type 2 diabetes: Review and critical appraisal of clinical practice guidelines.
| Author | Diab, Mohammad |
| Author | Barhoosh, Huda A |
| Author | Daoudi, Balqis |
| Author | AlMukdad, Sawsan I |
| Author | Zaghloul, Nancy Ha |
| Author | Ashour, Mayar |
| Author | Abdelrahman, Iman A |
| Author | Paravattil, Bridget |
| Author | Wilby, Kyle John |
| Available date | 2019-08-26T11:05:57Z |
| Publication Date | 2018-12-12 |
| Publication Name | Primary Care Diabetes |
| Identifier | http://dx.doi.org/10.1016/j.pcd.2018.11.014 |
| Citation | Diab, Mohammad et. al. , Prevention and screening recommendations in type 2 diabetes: Review and critical appraisal of clinical practice guidelines , primary care diabetes , Vol. 13 ( 2019 ) , P.p. 197–203 |
| ISSN | 1751-9918 |
| Abstract | The aim of this review was to identify and appraise guidelines reporting recommendations for the screening and prevention of type 2 diabetes. Five guidelines were included for analysis and all were endorsed by national or international organizations. All guidelines were recommended for practice with or without modifications for both prevention and screening. The overall appraisal scores ranged from 62.5 to 91.7 for prevention and 62.5-83.3 for screening. The highest scored domain was 'clarity of presentation' and the lowest was 'rigor of development'. Findings call for greater attention to rigor when formulating recommendations for prevention and screening of diabetes. |
| Language | en |
| Publisher | Elsevier |
| Subject | Appraisal Clinical practice guidelines Decision-making Diabetes |
| Type | Article |
| Pagination | 197–203 |
| Volume Number | 13 |
| ESSN | 1878-0210 |
Check access options
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Pharmacy Research [1365 items ]